サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423988

吸入麻酔市場、シェア、規模、動向、産業分析レポート：薬剤別、最終用途別、地域別、セグメント別予測、2024年～2032年

Inhalation Anesthesia Market Share, Size, Trends, Industry Analysis Report, By Drug (Sevoflurane, Desflurane, Isoflurane, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
吸入麻酔市場、シェア、規模、動向、産業分析レポート：薬剤別、最終用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の吸入麻酔市場規模は2032年までに34億2,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

入院期間の短縮に有効であることから、低侵襲手術の普及が進んでいることが市場成長に寄与しています。これらの手術は術後の痛みを軽減することが知られており、その結果、患者の鎮痛剤への依存度が低くなり、必要な投与量も少なくなります。

さらに、切開や縫合が少なくて済むため、入院期間も比較的短く、患者は定期的に病院に戻る必要がないです。Becker's Spine Reviewのデータによると、2020年12月現在、米国では160以上の外来手術センター（ASC）が低侵襲脊椎手術を行っており、過去10年間で大幅に増加しています。

緊急症例や外傷症例の増加は、患者の外来日帰り治療への嗜好の高まりと相まって、吸入麻酔市場の拡大に好影響を与えると思われます。

心疾患、神経血管疾患、その他の慢性疾患などの有病率の上昇は、幅広い外科的介入に対する需要を増加させる。疾病管理予防センターによると、毎年73万人以上のアメリカ人が心臓発作を起こしており、医療処置に対する需要の高まりを浮き彫りにしています。

吸入麻酔薬市場は、特定の外科手術における採用率の低下、ほぼすべてのハロゲン系薬剤のジェネリック競合の蔓延、最近の特許切れといった課題に直面しており、市場成長の妨げとなっています。

麻酔器メーカーは、電子式気化器、高度なモニタリング機能、人間工学に基づいた設計などの機能を取り入れることで、患者の安全性とヘルスケア環境における全体的なワークフローを改善することに注力しています。さらに、薬物動態プロファイルが改善され、環境への影響が少ない吸入麻酔薬の開発が重視されるようになっています。同市場では、麻酔管理プロトコルを合理化し、患者の転帰を最適化するために、製薬会社とヘルスケアプロバイダーのパートナーシップが拡大しています。

吸入麻酔市場レポートハイライト

2023年には、セボフルランセグメントが吸入麻酔市場で最大の売上シェアを占めました。セボフルランはその治療特性から、一般的に使用される麻酔薬です。セボフルランはエーテル系の吸入麻酔薬で、刺激性のない香り、低い刺激性、低い血液ガス分配係数を持っています。

予測期間中、病院セグメントが最も高い市場シェアを占めたが、これは病院で行われる手術に対する支援的な償還政策により、多くの外科手術の需要が増加しているためです。

2023年には、北米が吸入麻酔市場で最大の市場シェアを占めたが、これは不健康な食習慣や座りがちなライフスタイルの変化による慢性疾患の有病率の増加が市場の成長を促進するためです。

アジア太平洋地域は、健康問題に関する意識の高まりとヘルスケアへの支出の増加により、吸入麻酔市場で最も速い成長しました。様々な外科的介入を選択する患者が多数存在することが、同地域の市場成長を促進します。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の吸入麻酔市場に関する洞察

  • 吸入麻酔市場 - 最終用途のスナップショット
  • 吸入麻酔市場力学
    • 促進要因と機会
      • 手術件数の増加が市場の成長を促進
      • 救急症例の増加が市場の成長を促進する
    • 抑制要因と課題
      • 市場の成長を妨げる麻酔薬に関連する副作用と合併症
  • PESTEL分析
  • 吸入麻酔市場のエンド動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の吸入麻酔市場、薬剤別

  • 主な調査結果
  • イントロダクション
  • セボフルラン
  • デスフルラン
  • イソフルラン
  • その他

第6章 世界の吸入麻酔市場、用途別

  • 主な調査結果
  • イントロダクション
  • 導入
  • メンテナンス

第7章 世界の吸入麻酔市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来手術センター
  • その他

第8章 世界の吸入麻酔市場、地域別

  • 主な調査結果
  • イントロダクション
    • 吸入麻酔市場評価、地域、2019年～2032年
  • 吸入麻酔市場 - 北米
    • 北米：吸入麻酔市場、薬剤別、2019年～2032年
    • 北米：吸入麻酔市場、最終用途別、2019年～2032年
    • 北米：吸入麻酔市場、用途別、2019年～2032年
    • 吸入麻酔市場 - 米国
    • 吸入麻酔市場 - カナダ
  • 吸入麻酔市場 - 欧州
    • 欧州：吸入麻酔市場、薬剤別、2019年～2032年
    • 欧州：吸入麻酔市場、最終用途別、2019年～2032年
    • 欧州：吸入麻酔市場、用途別、2019年～2032年
    • 吸入麻酔市場 - 英国
    • 吸入麻酔市場 - フランス
    • 吸入麻酔市場 - ドイツ
    • 吸入麻酔市場 - イタリア
    • 吸入麻酔市場 - スペイン
    • 吸入麻酔市場 - オランダ
    • 吸入麻酔市場 - ロシア
  • 吸入麻酔市場 - アジア太平洋
    • アジア太平洋：吸入麻酔市場、薬剤別、2019年～2032年
    • アジア太平洋：吸入麻酔市場、最終用途別、2019年～2032年
    • アジア太平洋：吸入麻酔市場、用途別、2019年～2032年
    • 吸入麻酔市場 - 中国
    • 吸入麻酔市場 - インド
    • 吸入麻酔市場 - マレーシア
    • 吸入麻酔市場 - 日本
    • 吸入麻酔市場 - インドネシア
    • 吸入麻酔市場 - 韓国
  • 吸入麻酔市場 - 中東・アフリカ
    • 中東・アフリカ：吸入麻酔市場、薬剤別、2019年～2032年
    • 中東・アフリカ：吸入麻酔市場、最終用途別、2019年～2032年
    • 中東・アフリカ：吸入麻酔市場、用途別、2019年～2032年
    • 吸入麻酔市場 - サウジアラビア
    • 吸入麻酔市場 - アラブ首長国連邦
    • 吸入麻酔市場 - イスラエル
    • 吸入麻酔市場 - 南アフリカ
  • 吸入麻酔市場 - ラテンアメリカ
    • ラテンアメリカ：吸入麻酔市場、薬剤別、2019年～2032年
    • ラテンアメリカ：吸入麻酔市場、最終用途別、2019年～2032年
    • ラテンアメリカ：吸入麻酔市場、用途別、2019年～2032年
    • 吸入麻酔市場 - メキシコ
    • 吸入麻酔市場 - ブラジル
    • 吸入麻酔市場 - アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AbbVie Inc.
  • Baxter International Inc.
  • Dechra Pharmaceuticals PLC（Halocarbon Life Sciences LLC）
  • Fresenius Kabi AG（Fresenius SE & Co. KGaA）
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co. Ltd
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Limited
  • Troikaa Pharmaceuticals Ltd
図表

List of Tables

  • Table 1 Global Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 2 Global Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 4 Inhalation Anesthesia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 6 North America: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 9 U.S.: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 12 Canada: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 15 Europe: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 UK: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 18 UK: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 France: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 21 France: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 24 Germany: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 27 Italy: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 30 Spain: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 36 Russia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 China: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 42 China: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 44 India: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 45 India: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 51 Japan: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 57 South Korea: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 66 UAE: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 69 Israel: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 72 South Africa: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 75 Latin America: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 78 Mexico: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 81 Brazil: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • Table 84 Argentina: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Inhalation Anesthesia Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Inhalation Anesthesia Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Drug
  • Figure 9. Global Inhalation Anesthesia Market, by Drug, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Inhalation Anesthesia Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 12. Inhalation Anesthesia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Inhalation Anesthesia Market
目次
Product Code: PM4294

The global inhalation anesthesia market size is expected to reach USD 3.42 billion by 2032, according to a new study by Polaris Market Research. The report "Inhalation Anesthesia Market Share, Size, Trends, Industry Analysis Report, By Drug (Sevoflurane, Desflurane, Isoflurane, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of minimally invasive surgeries, driven by their effectiveness in reducing hospitalization durations, contributes to market growth. These procedures are known to reduce post-operative pain, resulting in less reliance on painkillers with lower dosage requirements for patients.

Furthermore, because fewer cuts or stitches are required, the hospitalization duration is comparatively shorter, and patients are not required to return to the hospital on a regular basis. According to Becker's Spine Review data, over 160 Ambulatory Surgical Centers (ASCs) in the United States are performing minimally invasive spine surgeries as of December 2020, representing a significant increase over the last decade.

The increase in emergency and trauma cases, combined with patients' increasing preference for ambulatory day care procedures, will have a positive impact on the expansion of the inhalation anesthesia market.

The rising prevalence of diseases such as cardiac disease, neurovascular disease, and other chronic conditions will increase the demand for a wide range of surgical interventions. According to the Centers for Disease Control and Prevention, over 730,000 Americans have a heart attack each year, highlighting the growing demand for medical procedures.

The market for inhalation anesthetics faces challenges such as lower adoption rates in specific surgical procedures, widespread generic competition for nearly all halogenated agents, and recent patent expirations, which hamper on market growth.

Anesthesia machine manufacturers have focused on incorporating features such as electronic vaporizers, advanced monitoring capabilities, and ergonomic designs to improve patient safety and overall workflow in healthcare settings. Furthermore, there has been a growing emphasis on the development of inhalation anesthetics with improved pharmacokinetic profiles and lower environmental impact. The market has witnessed a growing partnership between pharmaceutical companies and healthcare providers to streamline anesthesia management protocols and ensure optimal patient outcomes.

Inhalation Anesthesia Market Report Highlights

In 2023, the sevoflurane segment accounted for the largest revenue share in the inhalation anesthesia market, because of its therapeutic properties, sevoflurane is a commonly used anesthetic. It is an inhalation anesthetic in the ether class with a non-irritating aroma, low pungency, and a low blood gas partition coefficient.

The hospital segment accounted for the highest market share during the forecast period, owing to the increasing demand for numerous surgical procedures due to the supportive reimbursement policies for the surgeries being performed in the hospital.

In 2023, North America accounted for the largest market share in the inhalation anesthesia market, owing to the increasing prevalence of chronic diseases due to unhealthy dietary habit and sedentary lifestyle changes will facilitate the market's growth.

Asia Pacific region witnessed for the fastest growth in the inhalation anesthesia market due to the surging awareness regarding to the health issue and the increasing expenditure on healthcare in the region. Existence of a large number of patients who choose various surgical interventions will drive the market's growth in the region.

The global key market players include AbbVie Inc., Baxter International Inc., Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC), Fresenius Kabi AG (Fresenius SE & Co. KGaA), Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd, Lunan Pharmaceutical Group Co. Ltd, Merck KGaA, Piramal Enterprises Limited, and Troikaa Pharmaceuticals Ltd.

Polaris Market Research has segmented the inhalation anesthesia market report based on drug, application, end-use, and region:

Inhalation Anesthesia, Drug Outlook (Revenue - USD Billion, 2019 - 2032)

  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Others

Inhalation Anesthesia, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Induction
  • Maintenance

Inhalation Anesthesia, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Inhalation Anesthesia, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Inhalation Anesthesia Market Insights

  • 4.1. Inhalation Anesthesia Market - End-Use Snapshot
  • 4.2. Inhalation Anesthesia Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing number of surgeries will drive the growth of the market
      • 4.2.1.2. Rise in the number of emergency cases will bolster the growth of the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects and complications associated with anaesthetics hindering the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Inhalation Anesthesia Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Inhalation Anesthesia Market, by Drug

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
  • 5.3. Sevoflurane
    • 5.3.1. Global Inhalation Anesthesia Market, by Sevoflurane, by Region, 2019-2032 (USD Billion)
  • 5.4. Desflurane
    • 5.4.1. Global Inhalation Anesthesia Market, by Desflurane, by Region, 2019-2032 (USD Billion)
  • 5.5. Isoflurane
    • 5.5.1. Global Inhalation Anesthesia Market, by Isoflurane, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Inhalation Anesthesia Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Inhalation Anesthesia Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Induction
    • 6.3.1. Global Inhalation Anesthesia Market, by Induction, by Region, 2019-2032 (USD Billion)
  • 6.4. Maintenance
    • 6.4.1. Global Inhalation Anesthesia Market, by Maintenance, by Region, 2019-2032 (USD Billion)

7. Global Inhalation Anesthesia Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Inhalation Anesthesia Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Inhalation Anesthesia Market, by Ambulatory Surgical Centers, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Inhalation Anesthesia Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Inhalation Anesthesia Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Inhalation Anesthesia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Inhalation Anesthesia Market - North America
    • 8.3.1. North America: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
    • 8.3.2. North America: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Inhalation Anesthesia Market - U.S.
      • 8.3.4.1. U.S.: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Inhalation Anesthesia Market - Canada
      • 8.3.5.1. Canada: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Inhalation Anesthesia Market - Europe
    • 8.4.1. Europe: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Inhalation Anesthesia Market - UK
      • 8.4.4.1. UK: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Inhalation Anesthesia Market - France
      • 8.4.5.1. France: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Inhalation Anesthesia Market - Germany
      • 8.4.6.1. Germany: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Inhalation Anesthesia Market - Italy
      • 8.4.7.1. Italy: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Inhalation Anesthesia Market - Spain
      • 8.4.8.1. Spain: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Inhalation Anesthesia Market - Netherlands
      • 8.4.9.1. Netherlands: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Inhalation Anesthesia Market - Russia
      • 8.4.10.1. Russia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Inhalation Anesthesia Market - Asia Pacific
    • 8.5.1. Asia Pacific: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Inhalation Anesthesia Market - China
      • 8.5.4.1. China: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Inhalation Anesthesia Market - India
      • 8.5.5.1. India: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Inhalation Anesthesia Market - Malaysia
      • 8.5.6.1. Malaysia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Inhalation Anesthesia Market - Japan
      • 8.5.7.1. Japan: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Inhalation Anesthesia Market - Indonesia
      • 8.5.8.1. Indonesia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Inhalation Anesthesia Market - South Korea
      • 8.5.9.1. South Korea: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Inhalation Anesthesia Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Inhalation Anesthesia Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Inhalation Anesthesia Market - UAE
      • 8.6.5.1. UAE: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Inhalation Anesthesia Market - Israel
      • 8.6.6.1. Israel: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Inhalation Anesthesia Market - South Africa
      • 8.6.7.1. South Africa: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Inhalation Anesthesia Market - Latin America
    • 8.7.1. Latin America: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Inhalation Anesthesia Market - Mexico
      • 8.7.4.1. Mexico: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Inhalation Anesthesia Market - Brazil
      • 8.7.5.1. Brazil: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Inhalation Anesthesia Market - Argentina
      • 8.7.6.1. Argentina: Inhalation Anesthesia Market, by Drug, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Inhalation Anesthesia Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Inhalation Anesthesia Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Baxter International Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fresenius Kabi AG (Fresenius SE & Co. KGaA)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Hikma Pharmaceuticals PLC
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Jiangsu Hengrui Medicine Co. Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lunan Pharmaceutical Group Co. Ltd
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck KGaA
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Piramal Enterprises Limited
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Troikaa Pharmaceuticals Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development